References
- Abe, Y., Nakano, Y., Kanazawa, T., Furihata, T., Endo, T., & Kobayashi, M. (2016). Investigation of Drug–Drug Interactions Between Ritobegron, a Selective β3‐Adrenoceptor Agonist, With Probenecid in Healthy Men. Clinical Pharmacology in Drug Development, 5(3), 201–207. https://doi.org/https://doi.org/10.1002/cpdd.212
- Akocak, S., Lolak, N., Bua, S., & Supuran, C. T. (2018). Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors . Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 1575–1580. https://doi.org/https://doi.org/10.1080/14756366.2018.1515933
- Akocak, S., Lolak, N., Bua, S., Turel, I., & Supuran, C. T. (2018). Synthesis and biological evaluation of novel N,N'-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors . Bioorganic Chemistry, 77, 245–251. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.01.022
- Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C. T., & De Simone, G. (2012). Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chemical Reviews, 112(8), 4421–4468. https://doi.org/https://doi.org/10.1021/cr200176r
- Alterio, V., Hilvo, M., Di Fiore, A., Supuran, C. T., Pan, P., Parkkila, S., Scaloni, A., Pastorek, J., Pastorekova, S., Pedone, C., Scozzafava, A., Monti, S. M., & De Simone, G. (2009). Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proceedings of the National Academy of Sciences of the United States of America, 106(38), 16233–16238. https://doi.org/https://doi.org/10.1073/pnas.0908301106
- Arora, R., Issar, U., & Kakkar, R. (2019). Identification of novel urease inhibitors: Pharmacophore modeling, virtual screening and molecular docking studies. Journal of Biomolecular Structure & Dynamics, 37(16), 4312–4326. https://doi.org/https://doi.org/10.1080/07391102.2018.1546620
- Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., Felts, A. K., Halgren, T. A., Mainz, D. T., Maple, J. R., Murphy, R., Philipp, D. M., Repasky, M. P., Zhang, L. Y., Berne, B. J., Friesner, R. A., Gallicchio, E., & Levy, R. M. (2005). Integrated Modeling Program, Applied Chemical Theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780. https://doi.org/https://doi.org/10.1002/jcc.20292
- Becke, A. D. (1993). Becke’s three parameter hybrid method using the LYP correlation functional. Journal of Chemical Physics., 98(7), 5648–5652. https://doi.org/https://doi.org/10.1063/1.464913
- Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, Florida, November 11–17.
- Bozdag, M., Carta, F., Ceruso, M., Ferraroni, M., McDonald, P. C., Dedhar, S., & Supuran, C. T. (2018). Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX . Journal of Medicinal Chemistry, 61(14), 6328–6338. https://doi.org/https://doi.org/10.1021/acs.jmedchem.8b00770
- Carta, F., Supuran, C. T., & Scozzafava, A. (2014). Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Medicinal Chemistry, 6(10), 1149–1165. https://doi.org/https://doi.org/10.4155/fmc.14.68
- Carta, F., Vullo, D., Osman, S. M., AlOthman, Z., & Supuran, C. T. (2017). Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Bioorganic & Medicinal Chemistry, 25(9), 2569–2576. https://doi.org/https://doi.org/10.1016/j.bmc.2017.03.027
- Chahal, V., Nirwan, S., & Kakkar, R. (2019). Combined approach of homology modeling, molecular dynamics, and docking: Computer-aided drug discovery. Phys. Sci. Rev. 4(10). https://doi.org/https://doi.org/10.1515/psr-2019-0066
- Chahal, V., Nirwan, S., & Kakkar, R. (2020). A comparative study of the binding modes of SLC-0111 and its analogues in the hCA II and hCA IX active sites using QM/MM, molecular docking, MM-GBSA and MD approaches. Biophysical Chemistry, 265, 106439 https://doi.org/https://doi.org/10.1016/j.bpc.2020.106439
- Chen, C. H., Lin, Y. T., Yang, Y. H., Wang, L. C., Lee, J. H., Kao, C. L., & Chiang, B. L. (2008). Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, 19(2), 166–172. https://doi.org/https://doi.org/10.1111/j.1399-3038.2007.00610.x
- Deora, G. S., Joshi, P., Rathore, V., Kumar, K. L., Ohlyan, R., & Kandale, A. (2013). Pharmacophore modeling and 3D QSAR analysis of isothiazolidinedione derivatives as PTP1B inhibitors. Medicinal Chemistry Research, 22(7), 3478–3484. https://doi.org/https://doi.org/10.1007/s00044-012-0349-7
- Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10-11), 647–671. https://doi.org/https://doi.org/10.1007/s10822-006-9087-6
- Dubois, L., Peeters, S., Lieuwes, N. G., Geusens, N., Thiry, A., Wigfield, S., Carta, F., McIntyre, A., Scozzafava, A., Dogné, J.-M., Supuran, C. T., Harris, A. L., Masereel, B., & Lambin, P. (2011). Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 99(3), 424–431. https://doi.org/https://doi.org/10.1016/j.radonc.2011.05.045
- Eldehna, W. M., Abo-Ashour, M. F., Nocentini, A., El-Haggar, R. S., Bua, S., Bonardi, A., Al-Rashood, S. T., Hassan, G. S., Gratteri, P., Abdel-Aziz, H. A., & Supuran, C. T. (2019). Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. European Journal of Medicinal Chemistry, 162, 147–160. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.10.068
- Eldehna, W. M., Fares, M., Ceruso, M., Ghabbour, H. A., Abou-Seri, S. M., Abdel-Aziz, H. A., El Ella, D. A. A., & Supuran, C. T. (2016). Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. European Journal of Medicinal Chemistry, 110, 259–266. https://doi.org/https://doi.org/10.1016/j.ejmech.2016.01.030
- Gieling, R. G., & Williams, K. J. (2013). Carbonic anhydrase IX as a target for metastatic disease. Bioorganic & Medicinal Chemistry, 21(6), 1470–1476. https://doi.org/https://doi.org/10.1016/j.bmc.2012.09.062
- Golbraikh, A., & Tropsha, A. (2002). Beware of q2!. Journal of Molecular Graphics & Modelling, 20(4), 269–276. https://doi.org/https://doi.org/10.1016/s1093-3263(01)00123-1
- Güzel-Akdemir, Ö., Akdemir, A., Karalı, N., & Supuran, C. T. (2015). Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Organic & Biomolecular Chemistry, 13(23), 6493–6499. https://doi.org/https://doi.org/10.1039/c5ob00688k
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. https://doi.org/https://doi.org/10.1021/ci100275a
- Ibrahim, H. S., Abou-Seri, S. M., Tanc, M., Elaasser, M. M., Abdel-Aziz, H. A., & Supuran, C. T. (2015). Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII. European Journal of Medicinal Chemistry, 103, 583–593. https://doi.org/https://doi.org/10.1016/j.ejmech.2015.09.021
- John, A., Sivashanmugam, M., Umashankar, V., & Natarajan, S. K. (2017). Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads. Journal of Biomolecular Structure & Dynamics, 35(10), 2155–2168. https://doi.org/https://doi.org/10.1080/07391102.2016.1207565
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/https://doi.org/10.1063/1.445869
- Kakkar, R. (2011). Structure-based design of PDHK2 inhibitors from docking studies. International Research Journal of Pharmaceuticals, 1, 50–58.
- Kakkar, R., Arora, R., Gahlot, P., & Gupta, D. (2014). An insight into pyruvate dehydrogenase kinase (PDHK) inhibition through pharmacophore modeling and QSAR studies. Journal of Computational Science, 5(4), 558–567. https://doi.org/https://doi.org/10.1016/j.jocs.2014.04.006
- Khalili, J. S., Zhu, H., Sze, N., Mak, A., Yan, Y., & Zhu, Y. (2020). Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. Journal of Medical Virology, 92(7), 740–746. https://doi.org/https://doi.org/10.1002/jmv.25798
- Kumar, A., Rathi, E., & Kini, S. G. (2019). Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: Atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies. Journal of Biomolecular Structure and Dynamics., 1–15.
- Lee, C., Yang, W., & Parr, R. G. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review B Condensed Matter, 37(2), 785–789. https://doi.org/https://doi.org/10.1103/physrevb.37.785
- Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249. https://doi.org/https://doi.org/10.1016/S1056-8719(00)00107-6
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26. https://doi.org/https://doi.org/10.1016/s0169-409x(00)00129-0
- Lolak, N., Akocak, S., Bua, S., Koca, M., & Supuran, C. T. (2018). Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors . Bioorganic Chemistry, 77, 542–547. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.02.015
- Lolak, N., Akocak, S., Bua, S., Sanku, R. K., & Supuran, C. T. (2019). Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors . Bioorganic & Medicinal Chemistry, 27(8), 1588–1594. https://doi.org/https://doi.org/10.1016/j.bmc.2019.03.001
- Lolak, N., Akocak, S., Bua, S., & Supuran, C. T. (2019). Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors . Bioorganic Chemistry, 82, 117–122. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.10.005
- Lopez, M., Bornaghi, L. F., Innocenti, A., Vullo, D., Charman, S. A., Supuran, C. T., & Poulsen, S. A. (2010). Sulfonamide Linked neoglycoconjugates-a new class of inhibitors for cancer-associated carbonic anhydrases . Journal of Medicinal Chemistry, 53(7), 2913–2926. https://doi.org/https://doi.org/10.1021/jm901888x
- Lu, C. L., Zhou, L., Li, Z. C., Gao, X., & Zhang, W. (2012). Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors. Medicinal Chemistry Research, 21(11), 3417–3427. https://doi.org/https://doi.org/10.1007/s00044-011-9868-x
- Martyna, G. J., Klein, M. L., & Tuckerman, M. (1992). Nosé-Hoover chains: The canonical ensemble via continuous dynamics. Journal of Chemical Physics, 97(4), 2635–2643. https://doi.org/https://doi.org/10.1063/1.463940
- Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. Journal of Chemical Physics., 101(5), 4177–4189. https://doi.org/https://doi.org/10.1063/1.467468
- McDonald, P. C., Winum, J. Y., Supuran, C. T., & Dedhar, S. (2012). Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget, 3(1), 84–97. https://doi.org/https://doi.org/10.18632/oncotarget.422
- Metayer, B., Martin-Mingot, A., Vullo, D., Supuran, C. T., & Thibaudeau, S. (2013). Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: Toward understanding a new mode of inhibition by tertiary sulfonamides. Organic & Biomolecular Chemistry, 11(43), 7540–7549. https://doi.org/https://doi.org/10.1039/c3ob41538d
- Monti, S. M., Supuran, C. T., & De Simone, G. (2013). Anticancer carbonic anhydrase inhibitors: A patent review (2008 - 2013). Expert Opinion on Therapeutic Patents, 23(6), 737–749). https://doi.org/https://doi.org/10.1517/13543776.2013.798648
- Nirwan, S., Chahal, V., & Kakkar, R. (2020). Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1712258
- Nocentini, A., & Supuran, C. T. (2019). Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opinion on Drug Discovery, 14(11), 1175–1197. https://doi.org/https://doi.org/10.1080/17460441.2019.1651289
- Parks, S. K., Chiche, J., & Pouyssegur, J. (2011). pH control mechanisms of tumor survival and growth. Journal of Cellular Physiology, 226(2), 299–308. https://doi.org/https://doi.org/10.1002/jcp.22400
- Pastorekova, S., Zatovicova, M., & Pastorek, J. (2008). Cancer-associated carbonic anhydrases and their inhibition. Current Pharmaceutical Design, 14(7), 685–698. https://doi.org/https://doi.org/10.2174/138161208783877893
- Popsavin, M., Kojić, V., Torović, L., Svirčev, M., Spaić, S., Jakimov, D., Aleksić, L., Bogdanović, G., & Popsavin, V. (2016). Synthesis and in vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2' position. European Journal of Medicinal Chemistry, 111, 114–125. https://doi.org/https://doi.org/10.1016/j.ejmech.2016.01.037
- Rastelli, G., Rio, A. D., Degliesposti, G., & Sgobba, M. (2010). Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA . Journal of Computational Chemistry, 31(4), 797–810. https://doi.org/https://doi.org/10.1002/jcc.21372
- Sterling, T., & Irwin, J. J. (2015). ZINC 15-Ligand Discovery for Everyone. Journal of Chemical Information and Modeling, 55(11), 2324–2337. https://doi.org/https://doi.org/10.1021/acs.jcim.5b00559
- Sun, H., Li, Y., Tian, S., Xu, L., & Hou, T. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Physical Chemistry Chemical Physics : Pccp, 16(31), 16719–16729. https://doi.org/https://doi.org/10.1039/c4cp01388c
- Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews. Drug Discovery, 7(2), 168–181. https://doi.org/https://doi.org/10.1038/nrd2467
- Supuran, C. T. (2011). Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Medicinal Chemistry, 3(9), 1165–1180. https://doi.org/https://doi.org/10.4155/fmc.11.69
- Supuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G. (2018). Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one. Medicinal Research Reviews, 38(6), 1799–1836. https://doi.org/https://doi.org/10.1002/med.21497
- Supuran, C. T., & Winum, J. Y. (2015). Carbonic anhydrase IX inhibitors in cancer therapy: An update. Future Medicinal Chemistry, 7(11), 1407–1414. https://doi.org/https://doi.org/10.4155/fmc.15.71
- Swords, R. T., Coutre, S., Maris, M. B., Zeidner, J. F., Foran, J. M., Cruz, J., Erba, H. P., Berdeja, J. G., Tam, W., Vardhanabhuti, S., Pawlikowska-Dobler, I., Faessel, H. M., Dash, A. B., Sedarati, F., Dezube, B. J., Faller, D. V., & Savona, M. R. (2018). Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood , 131(13), 1415–1424. https://doi.org/https://doi.org/10.1182/blood-2017-09-805895
- Thiry, A., Dogne, J. M., Masereel, B., & Supuran, C. T. (2006). Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends in Pharmacological Sciences, 27(11), 566–573. https://doi.org/https://doi.org/10.1016/j.tips.2006.09.002
- Toukmaji, A. Y., & Board, J. A. Jr, (1996). Ewald summation techniques in perspective: A survey. Computer Physics Communications., 95(2-3), 73–92. https://doi.org/https://doi.org/10.1016/0010-4655(96)00016-1
- Vitale, M., Zamai, L., Falcieri, E., Zauli, G., Gobbi, P., Santi, S., Cinti, C., & Weber, G. (1997). IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells. Cytometry A, 30(1), 61–66. https://doi.org/https://doi.org/10.1002/(SICI)1097-0320(19970215)30:1<61::AID-CYTO9>3.0.CO;2-I
- Wilson, W. R., & Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nature Reviews. Cancer, 11(6), 393–410. https://doi.org/https://doi.org/10.1038/nrc3064
- Yang, J. M., Chen, Y. F., Shen, T. W., Kristal, B. S., & Hsu, D. F. (2005). Consensus scoring criteria for improving enrichment in virtual screening. Journal of Chemical Information and Modeling, 45(4), 1134–1146. https://doi.org/https://doi.org/10.1021/ci050034w